31 results
6-K
CNTB
Connect Biopharma Holdings Limited
5 Sep 24
Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update
4:20pm
of clinical operations and development, drug manufacturing, and other research and development employees, offset by severance expenses.
Administrative … , offset by negative working capital change in our operating assets and liabilities of US$17.8 million. The adjustments consisted primarily of share
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Limited
5 Sep 24
Connect Biopharma Reports First Half 2024 Financial Results and Provides Business Update
4:20pm
. The decrease was mainly due to cash used to advance the Company’s clinical programs and fund its operations, offset by partnership payments received from
6-K
EX-10.3
CNTB
Connect Biopharma Holdings Limited
12 Jun 24
Current report (foreign)
4:47pm
be offset by the Company Group or its affiliates against amounts payable to Executive under this Section 4.
(g) Return of the Company’s Property
6-K
EX-10.1
CNTB
Connect Biopharma Holdings Limited
12 Jun 24
Current report (foreign)
4:47pm
pursuant to Section 3 below. Upon exercise of the Option, the Company or the Grantee’s employer shall have the right to offset or withhold (from any amount
6-K
EX-10.2
CNTB
Connect Biopharma Holdings Limited
12 Jun 24
Current report (foreign)
4:47pm
, however, that loans, advances or other amounts owed by Executive to the Company Group or its affiliates may be offset by the Company Group or its affiliates
6-K
EX-99.1
74yu16l 4er
16 Apr 24
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
4:20pm
6-K
EX-99.1
tgyadz5466kpjcprc8
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
6-K
zlfpph2b 51jw08ji
12 Sep 23
Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update
4:47pm
6-K
EX-99.1
ovu4r tl3
23 Jun 23
House Lease Contract
4:31pm
6-K
vil1ub3v pr
13 Sep 22
Connect Biopharma Reports First Half 2022 Financial Results
4:47pm
F-3/A
cnn5mby4l0m62vjv
17 Jun 22
Shelf registration (foreign) (amended)
5:19pm
F-3/A
fft4nyp
20 May 22
Shelf registration (foreign) (amended)
6:54pm
F-3
7jk3lqo0i
15 Apr 22
Shelf registration (foreign)
5:27pm
20-F
EX-4.13
6xwl0vbchsm1h6 vs
31 Mar 22
Annual report (foreign)
4:33pm
20-F
rkaibgn uz4b0
31 Mar 22
Annual report (foreign)
4:33pm
6-K
EX-99.2
ut1 gye6xba6kesidn
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm
6-K
EX-99.2
l4ljqy1t xyg2
3 Jun 21
Development program exploring the potential of CBP-174 in the treatment of chronic inflammatory pruritus
6:04am